By conjugating biomimetic cell membranes with dendritic cationic peptides, DNase I-loaded nanogels can be targeted to the joints of mice and subsequently alleviated RA symptoms in CIA mice via suppressing the TLR9 pathway (66). This evidence concerns the gene DNASE1 and rheumatoid arthritis.